Summary A case-control study was undertaken to investigate the role of diet in women with breast cancer, and in two groups of women with benign breast disease: epithelial hyperplasia, and fibrocystic disease without hyperplasia.
Before we can devise ways of preventing breast cancer from developing, causative factors must be identified. Of those identified to date, diet has aroused the greatest interest and debate because of its potential for preventing breast cancer.
The early international correlation studies clearly associated animal fat consumption with breast cancer mortality (Armstrong & Doll, 1975 ), yet case-control studies have, on the whole, failed to confirm that a diet rich in fat increases the risk of developing breast cancer (Goodwin & Boyd, 1987) . There are a number of reasons why case-control studies may not detect differences in diet between breast cancer patients and their controls, if such differences do in fact exist. Amongst them is the likelihood that any influence of nutrition on the breast to increase its susceptibility to cancer probably takes place a decade or more before the breast cancer becomes clinically apparent (Ingram, 1981) , and in the intervening period the patient's dietary habits may have changed.
In an attempt to overcome this problem, we have undertaken a case-control study which includes not only breast cancer patients and their controls, but also a group at increased risk of developing breast cancer, women with benign epithelial hyperplasia of the breast (BEH). Hyperplasia of the breast epithelium has been identified as a change which probably precedes breast malignancy (Dupont & Page, 1985) , and although the time interval is uncertain, it is likely to be at least a decade. In addition, patients at low risk of developing breast cancer, women with benign fibrocystic disease of the breast without histological evidence of hyperplasia (FCD), were studied as a control group, as well as a group of community controls. If nutrition were to play a part in breast cancer development, one would expect the dietary intake of the low-risk group (FCD) Statistical analysis Quartiles for each nutrient and food group were derived from the control populations, and the odds ratio and 95% confidence limits determined by conditional logistic regression. These were determined both for quartiles and at the median level of consumption. Significant associations were recalculated after adjusting for known risk factors for breast cancer: parity, first-degree family history of breast cancer, age at menarche and body mass index.
The mean consumption of each nutrient and food group were calculated for each patient group and their control. Means were compared by one-way analysis of variance.
Results
Study population (Table I) A comparison of patient and control characteristics and risk factors for each of the study groups is shown in Table I . The only significant differences between cases and controls were for family history and indices of obesity. Nineteen per cent of cancer patients had a first-degree relative with breast cancer, compared with 8.7% of the controls (P<0.05). Ten per cent of BEH patients had a positive family history of breast cancer, compared with 6% of controls, but this did not reach significance. BEH patients weighed less and had a lower body mass index than controls. These results have been presented and discussed previously (Ingram et al., 1989) . The breast cancer patients' lower parity when compared with controls, and their lower age at menarche, did not reach statistical significance.
Estimations of risk (Table II) After estimation of the odds ratio for consumption of each nutrient, the only significant finding was for the proportion of energy derived from sugar, this being protective for benign epithelial hyperplasia. When examined by quartiles, an additional significant finding was of a protective effect for vitamin C consumption, with fibrocystic disease in the highest quartile of consumption (O.R 0.4, c.l. 0.1-0.9). An The significant associations were recalculated after adjusting for possible confounding variables. The previously significant elevated odds ratios for red meat and for snacks (Table  HIc) Benign epithelial hyperplasia patients consumed significantly less chicken and seafood and less fruit than controls. Again, similar patterns of consumption are seen for the cancer patients, but also not quite to a significant level.
The fibrocystic group were found to consume significantly less vitamin C and yellow-orange fruit than controls, and more polyunsaturated fats.
Change in diet (Tables III and IV) As there was concern that a recent diagnosis of breast cancer might have influenced a subject's diet, all subjects were asked (Table IV) .
As there was a considerable difference between the number of cancer patients and their controls who had changed their diet recently, the statistics were recalculated for these groups after exclusion of those who had changed their diet (Table  III) . This reanalysis resulted in consumption of starches (O.R. 2.0) and of monounsaturated fats (O.R. 2.3) from the nutrient analysis, and of butter and margarine (O.R. 2.3) and mean (O.R. 2.0) from the food group analysis, now becoming significant variables (Table II) . Reanalysis of the mean consumption (Table III) had little effect on the overall results, but did increase the mean consumption of fats and reduce the mean consumption of fibre and vitamins for the cancer patients. These changes were also seen in the food group analyses where the mean consumption of cakes etc., butter and margarine, meat and savoury meals increased and the consumption of fruit decreased.
In addition, each woman was asked how her eating patterns had changed over the past 10 years (Table V) (1987) published a 0.6-2.0 0.8-2.7 0.6-1.9 0.9-2.6 0.8-2.4 0.8-2.5 0.6-1.8 0.9-2.9 0.4-1.7 0.9-2.6 0.6-1.7 0.5-1.4 0.7-2.2 0.7-2.3 0.8-2.6 0.6-1.8 0.8-2.4 0.4-1.1 0.7-2.4 0.6-1.9 0.7-2.6 0.3-1.1 0.5-1.6 0.5-1.5 0.7-2.2 0.5-1.6 0.6-1.8 0.7-2.0 0.9-2.8 1.0-3.2a 0.5-1.6 1.0-2.9 0.6-1.8 1.0-3.8a 0.5-1.6 0.6-2.0 0.5-1.8 0.8-2.4 0.6-1.7 0.5-1.6 detailed critical analysis of all studies published on the subject to that time. Howe et al. (1990) have recently conducted a combined analysis of the original data from 12 case-control studies. Their results show a consistent, statistically significant, positive association between breast cancer risk and saturated fat consumption in postmenopausal women, the relative risk for highest vs lowest quintiles being 1.46 (P<0.0001). In addition, a consistent protective effect for a number of markers of fruit and vegetable intake was demonstrated. For Vitamin C, the relative risk of highest vs lowest quintile was 0.69 (P<0.0001).
At odds with these results are those of the two large North American cohort studies. A study of 89,538 nurses by Willett et al. (1987) and of 5,485 women by Jones et al. (1987) failed to find any evidence of a positive association between breast cancer risk and fat intake. Indeed, the relative risk for the highest vs lowest quintile of saturated fat in postmenopausal women was only 0.79 in Willett's study, and similarly Jones' study showed an apparent protective effect of high fat intake. To resolve the discrepancy in results between these cohort studies and the case-control studies and correlation studies, further analytic epidemiological data need to be acquired.
A number of findings of interest have arisen from the study. The consumption of starches, particularly from vegetables, appeared to be disadvantageous, and is seen in both the BEH and cancer groups. Such a finding is difficult to explain, and no mechanisms is apparent. The consumption of savoury foods such as pizzas, stews, etc and the consumption of red meat appeared to be detrimental, while the consumption of chicken and seafood were beneficial. In general, these findings are also present in both the BEH and cancer groups. Unfortunately, the dietary analysis program does not allow separation of the poultry and fish groups so that the apparent beneficial effect of these could be explored further. The above findings would suggest that the type of fat consumed may be important; however, in the analysis by breakdown into nutrients, it is only the consumption of monounsaturated fats which differs between cases and controls, and then only at the highest quartile of consumption.
The consumption of fruit appears to be beneficial, again these findings being apparent for both the BEH and the breast cancer groups. Presumably this beneficial effect is through anti-oxidants in the food, but surprisingly no significant differences for beta-carotene or vitamin C are seen between cases and controls, although the BEH group does have a considerably lower consumption of these than the controls. As hypothesised, only occasional significant associations were seen for the FCD group, and in general consumption of nutrients and food groups were similar to the controls.
If recommendations were to be made from these data as to a diet which might help reduce the incidence of breast cancer, they would be similar to those of the generally promoted 'healthy' diet of a reduced consumption of red meats and prepared foods, and an increased consumption of poultry, fish, fruit and vegetables. It is of note that, while the data in Table V suggests that the populace is already moving towards such a diet, the women in the breast cancer group were the least likely to have made changes over this time.
